Fri 27 Nov 2009 | 4:42 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Dendreon Corp

Dendreon Corp (DNDN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View DNDN on other exchanges
As of  25 Nov 2009
27.69USD
Price Change
+0.49
Percent Change
+1.80%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Urdal, David 59 2004 Senior Vice President, Chief Scientific Officer, Director
Hamm, Richard 49 2006 Senior Vice President - Corporate Development, General Counsel, Secretary
Frohlich, Mark 47 2008 Senior Vice President - Clinical Affairs, Chief Medical Officer
Gold, Mitchell 42 2003 President, Chief Executive Officer, Director
Canet, Gerardo 63 1996 Director
Watson, Douglas 64 2000 Director
Dziurzynski, Bogdan 60 2001 Director
Bayh, Susan 49 2003 Director
Clark, Ian 48 2009 Director
Granadillo, Pedro 62 2009 Director
Schiffman, Gregory 51 2006 Chief Financial Officer, Senior Vice President, Treasurer
Brewer, Richard 58 2004 Chairman of the Board